FB、微软投诉苹果应用商店不当处理游戏应用 引起欧盟关注
《路透》报道,脸书(Facebook)及微软(Microsoft)不满苹果在应用程式商店(App Store)处理旗下游戏应用的手法,或招来欧盟反垄断机构的调查。欧盟称留意到脸书及微软的投诉。
欧盟6月对苹果展开四项调查,其中三项涉及应用程式商店及相关规定,包括规定软件开发商使用苹果的购买系统。苹果否认有关做法有问题,称所有应用面对相同规则,以保障消费者及为开发商提供公平竞争环境。
脸书上周投诉其游戏应用只能在苹果应用程式商店作为串流服务,使用者无法玩游戏,并指公司被迫移除所有游戏功能,才能在苹果应用程式商店上架。微软亦批评苹果为唯一阻止消费者参与云端游戏或游戏订阅服务的平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.